Frequency of Cognitive Dysfunction in Patients With Chronic Low Back Pain
CompletedNCT06278467
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This study evaluates cognitive dysfunction status and related factors in patients with chronic low back pain over the age of 60.
Study details
- Official title
- Frequency of Cognitive Dysfunction and Related Factors in Patients With Chronic Low Back Pain
- Conditions
- Cognitive Dysfunction
- Low Back Pain
- Interventions
- Diagnostic test: visual pain scale (VASpain/fatigue), Beck depression index (BDI),
- Diagnostic test: Pain catastrophizing scale, sleep quality with a single Likert type question in the Pittsburgh questionnaire
- Diagnostic test: Roland Morris Disability Questionnaire, quality of life with Short Form-36 ( SF-36),
- Diagnostic test: Montreal Cognitive Assessment Scale (MOCA)
- Standard Mini mental test (SMMT)
- Sponsor
- Konya Beyhekim Training and Research Hospital
- Start date
- 2022-03-01
- Primary completion
- 2023-12-15
- Sex
- All
- Age range
- from 60 Years to 85 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Turkey (Türkiye)
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: Being over 60 years old Having a history of low back pain lasting more than 6 months and being diagnosed with CBP Having pain of at least 3 intensity according to VAS Exclusion Criteria: Those under 60 years of age * Those with neurological deficits * Those with inflammatory low back pain * Those with rheumatic diseases such as fibromyalgia, polymyalgia rheumatica, ankylosing spondylitis, rheumatoid arthritis * Having undergone surgery in the lumbar region within the last 6 months * Those with widespread pain, those with significant pain in another anatomical location (e.g. gonarthrosis) * Those who use drugs or substances (alcohol, drugs, etc.) that may cause cognitive impairment * Those with known neurological diseases such as cerebrovascular disease, MS, Parkinson's, dementia * Those with major psychiatric illness * Those with communication problems * Those who have started psychiatric medical treatment within the last three months * Those with significant hearing or vision problems * Those with a history of uncontrolled systemic disease (cardiovascular, pulmonary, hepatic, renal, hematological, endocrine, etc.)
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06278467